Comment by pama

The drug candidates that enter human clinical trials, (phase 1 to phase 3) are identical in all ways to the final product if approved. The company is not allowed to change any part of the manufacturing process. All the research for how to make the drug is done in preclinical phases. In the clinical phase we test the unknown human biology with a final product candidate.